Yu Tang
No. 266 Xincun West Road
Zibo, 255049, China
Zibo, 255049, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Corrigendum to "PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer" [Cancer Lett. 598 (2024) 217112].
Journal: Cancer letters
Published: June 30, 2026
Optimization of Magnetic Finishing Process and Surface Quality Research for Inner Wall of MP35N Cobalt-Chromium Alloy Vascular Stent Tubing Based on Plasma-Fused Al2O3 Magnetic Abrasives.
Journal: Micromachines
Published: April 14, 2025
Lactylation and human disease.
Journal: Expert reviews in molecular medicine
Published: February 03, 2025
Studies on the functional role of UFMylation in cells (Review).
Journal: Molecular medicine reports
Published: January 15, 2025
Differentiated Modulating the Electronic Structure of NiFe@Ni/Fe-MnOx via Phase Transformation Engineering to Synergy Promote Bifunctional Water Splitting Reactions.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: November 12, 2024
Positive Feedback Regulation between KLF5 and XPO1 Promotes Cell Cycle Progression of Basal like Breast Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 29, 2024
Advances in the study of the role of high-frequency mutant subunits of the SWI/SNF complex in tumors.
Journal: Frontiers in oncology
Published: July 12, 2024
An Experimental Study in Laser-Assisted Machining of AerMet100 Steel.
Journal: Micromachines
Published: June 20, 2024
Advances in research on the relationship between the LMNA gene and human diseases (Review).
Journal: Molecular medicine reports
Published: June 18, 2024
Targeting the HECTD3-p62 axis increases the radiosensitivity of triple negative breast cancer cells.
Targeting the HECTD3-p62 axis increases the radiosensitivity of triple negative breast cancer cells.
Journal: Cell death discovery
Published: April 16, 2024
PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer.
Journal: Cancer letters
Published: March 13, 2024
Last Updated: 09/26/2026